RNA-Guided Human Genome Engineering
First Claim
1. A method of altering a eukaryotic cell comprisingproviding to the eukaryotic cell a guide RNA sequence complementary to a target nucleic acid sequence of genomic DNA of the eukaryotic cell, andproviding to the eukaryotic cell a Cas 9 protein that interacts with the guide RNA and cleaves the genomic DNA in a site specific manner.
2 Assignments
0 Petitions
Accused Products
Abstract
A method of altering a eukaryotic cell is provided including transfecting the eukaryotic cell with a nucleic acid encoding RNA complementary to genomic DNA of the eukaryotic cell, transfecting the eukaryotic cell with a nucleic acid encoding an enzyme that interacts with the RNA and cleaves the genomic DNA in a site specific manner, wherein the cell expresses the RNA and the enzyme, the RNA binds to complementary genomic DNA and the enzyme cleaves the genomic DNA in a site specific manner.
-
Citations
24 Claims
-
1. A method of altering a eukaryotic cell comprising
providing to the eukaryotic cell a guide RNA sequence complementary to a target nucleic acid sequence of genomic DNA of the eukaryotic cell, and providing to the eukaryotic cell a Cas 9 protein that interacts with the guide RNA and cleaves the genomic DNA in a site specific manner.
-
8. A method of altering expression of a gene product comprising introducing into a eukaryotic cell containing and expressing a DNA molecule having a target sequence and encoding the gene product an engineered Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR associated (Cas) (CRISPR-Cas) system comprising:
-
a) a first regulatory element operable in a eukaryotic cell operably linked to at least one nucleotide sequence encoding a CRISPR-Cas system guide RNA that hybridizes with the target sequence, and b) a second regulatory element operable in a eukaryotic cell operably linked to a nucleotide sequence encoding a Type-II Cas9 protein, wherein components (a) and (b) are located on different vectors of the system, whereby the guide RNA targets the target sequence and the Cas9 protein cleaves the DNA molecule, whereby expression of the at least one gene product is altered. - View Dependent Claims (9, 10, 11, 12, 13)
-
-
14. An engineered CRISPR-Cas system comprising:
-
a) a first regulatory element operable in a eukaryotic cell operably linked to at least one nucleotide sequence encoding a CRISPR-Cas system guide RNA that hybridizes with a target sequence of a DNA molecule in a eukaryotic cell that contains the DNA molecule, wherein the DNA molecule encodes and the eukaryotic cell expresses a gene product, and b) a second regulatory element operable in a eukaryotic cell operably linked to a nucleotide sequence encoding a Type-II Cas9 protein, wherein components (a) and (b) are located on different vectors of the system, whereby the guide RNA targets and hybridizes with the target sequence and the Cas9 protein cleaves the DNA molecule, whereby expression of the gene product is altered. - View Dependent Claims (15, 16, 17, 18, 19)
-
-
20. An engineered Type II CRISPR-Cas system comprising a Cas9 protein and at least one guide RNA that targets and hybridizes to a target sequence of a DNA molecule in a eukaryotic cell, wherein the DNA molecule encodes and the eukaryotic cell expresses a gene product and the Cas9 protein cleaves the DNA molecule,
whereby expression of the gene product is altered.
Specification